CRYZ Antibody (N-term) Blocking Peptide

Artikelnummer: ABT-BP6566A
Artikelname: CRYZ Antibody (N-term) Blocking Peptide
Artikelnummer: ABT-BP6566A
Hersteller Artikelnummer: BP6566a
Alternativnummer: ABT-BP6566A-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Quinone oxidoreductase, NADPH:quinone reductase, Zeta-crystallin, CRYZ
Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. The former class is also called phylogenetically-restricted crystallins. CRYZ is a taxon-specific crystallin protein which has NADPH-dependent quinone reductase activity distinct from other known quinone reductases. It lacks alcohol dehydrogenase activity although by similarity it is considered a member of the zinc-containing alcohol dehydrogenase family. Unlike other mammalian species, in humans, lens expression is low.
NCBI: 1429
UniProt: Q08257
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP6566a was selected from the N-term region of human CRYZ. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.